RFG Advisory LLC Has $474,000 Stake in Stryker Co. (NYSE:SYK)

RFG Advisory LLC decreased its stake in shares of Stryker Co. (NYSE:SYK) by 4.7% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,324 shares of the medical technology company’s stock after selling 65 shares during the quarter. RFG Advisory LLC’s holdings in Stryker were worth $474,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of SYK. Norges Bank acquired a new stake in shares of Stryker during the 4th quarter worth approximately $1,260,562,000. Price T Rowe Associates Inc. MD grew its position in shares of Stryker by 5.4% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,541,845 shares of the medical technology company’s stock worth $3,755,782,000 after buying an additional 642,178 shares during the period. Confluence Investment Management LLC acquired a new stake in shares of Stryker during the 1st quarter worth approximately $93,369,000. Morgan Stanley grew its position in Stryker by 4.4% in the 3rd quarter. Morgan Stanley now owns 5,315,227 shares of the medical technology company’s stock valued at $1,452,493,000 after purchasing an additional 223,728 shares during the period. Finally, The Manufacturers Life Insurance Company grew its position in Stryker by 24.2% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 1,115,955 shares of the medical technology company’s stock valued at $304,957,000 after purchasing an additional 217,672 shares during the period. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on SYK shares. UBS Group lifted their price target on shares of Stryker from $339.00 to $351.00 and gave the company a “neutral” rating in a research report on Wednesday, May 1st. BTIG Research lifted their price target on shares of Stryker from $366.00 to $369.00 and gave the company a “buy” rating in a research report on Wednesday, May 1st. Barclays lifted their price target on shares of Stryker from $372.00 to $376.00 and gave the company an “overweight” rating in a research report on Thursday, May 2nd. Stifel Nicolaus lifted their price target on shares of Stryker from $350.00 to $375.00 and gave the company a “buy” rating in a research report on Wednesday, May 1st. Finally, The Goldman Sachs Group started coverage on shares of Stryker in a report on Thursday, May 30th. They set a “neutral” rating and a $372.00 price objective on the stock. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, Stryker presently has a consensus rating of “Moderate Buy” and a consensus target price of $370.58.

Stryker Trading Down 1.0 %

NYSE SYK opened at $339.19 on Tuesday. The stock has a market capitalization of $129.21 billion, a price-to-earnings ratio of 38.72, a PEG ratio of 2.70 and a beta of 0.92. Stryker Co. has a one year low of $249.98 and a one year high of $361.41. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.71 and a quick ratio of 0.99. The business’s fifty day moving average is $336.69 and its 200-day moving average is $332.60.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Tuesday, April 30th. The medical technology company reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.36 by $0.14. Stryker had a return on equity of 23.05% and a net margin of 16.03%. The business had revenue of $5.24 billion for the quarter, compared to analysts’ expectations of $5.10 billion. During the same period in the previous year, the business posted $2.14 EPS. The firm’s quarterly revenue was up 9.7% compared to the same quarter last year. Equities research analysts predict that Stryker Co. will post 11.95 EPS for the current year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Investors of record on Friday, June 28th will be paid a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date is Friday, June 28th. Stryker’s dividend payout ratio is currently 36.53%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.